Washington, D.C. Newsroom, Jul 28, 2020 / 04:00 pm MT (CNA).- As coronavirus vaccine prototypes move closer to testing and approval, some Catholics are debating the ethical sources behind a leading vaccine candidate.
On Monday, President Donald Trump announced that the vaccine mRNA-1273, co-designed by the biotechnology company Moderna and the National Institute of Allergy and Infectious Diseases (NIAID), had entered phase 3 of clinical trials. The vaccine will soon be tested for safety, and to confirm that it can effectively prevent COVID-19 in two doses.
Dr. Anthony Fauci, director of NIAID and White House health advisor, said on Monday that a vaccine is urgently required to control this pandemic, but has also cautioned in recent days that, despite speedy progress, a vaccine might not be widely available until several months into 2021.
The Trump administration is funding vaccine candidates as part of Operation Warp Speed, making investments in vaccine candidates from Novavax, Moderna, AstraZeneca, and Janssen. It is also investing $1.95 billion with Pfizer to facilitate the delivery of 100 million doses after a vaccine is developed.
On Monday Fauci said that early testing of the Moderna vaccine indicates that it is safe and immunogenic.
While demand for a vaccine is urgent, questions have been raised by some pro-life advocates about the Moderna candidate, and its ethical development - specifically, whether it has been tested using a fetal cell line taken from an aborted baby.
The Charlotte Lozier Institute, research arm of the pro-life Susan B. Anthony List, has listed the Moderna vaccine among the ethically uncontroversial CoV-19 vaccine programs, along with development projects from Inovio Pharmaceuticals, Sanofi & Translate Bio, Pfizer and BioNTech, Novavax, and Merck/IAVI.
According to CLI, two vaccine candidates are the product of unethical programsthose being developed by the University of Oxford and Astrazeneca, and by Johnson & Johnson and Janssen Res. & Devel., Inc.
On the straightforward question of whether the Moderna vaccine is being produced from cell lines from elective abortions, Dr. John Brehany, director of institutional relations at the National Catholic Bioethics Center, said it appears that the answer is no.
Vaccines use a weakened version of a disease, grown in laboratory cell lines, in order to inoculate someone against the disease. With some common vaccines, such as those used to fight chicken pox and measles, mumps, and rubella (MMR), the cell lines of babies who were aborted decades ago are used to grow the weakened diseases.
This is also reportedly the case with some coronavirus vaccines in development, such as one worked on by the University of Oxford and Astrazeneca, which relies on the HEK-239 cell lines from a baby aborted in the Netherlands in the 1970s. That program is also being funded by the Trump administrations Operation Warp Speed.
But the Moderna vaccine works in different way than most vaccines. Its method of innoculation is not based on using cells at all in production, Brehany said.
The Moderna vaccine relies upon a spike protein from SARS-CoV-2 to induce the production of antibodies in the recipient, instead of a weakened version of the disease.
The gene sequences for the spike protein were determined to be a good candidate for producing a vaccine.
Non-Moderna scientists had initially made DNA vectors with the gene sequence of the spike protein, and injected them in HEK-293 cells to produce the spike protein. That work was studied and evaluated by experts at NIAID and the University of Texas, who determined that the spike protein was a good candidate for testing. Moderna was not involved in the DNA construction nor was it involved in the evaluation of the construction.
Thus, Brehany said, while the company has some association with the use of cell lines from elective abortions, it is not responsible for that use, and its vaccine was not produced using those HEK-293 cells.
A 2005 document from the Pontifical Academy for Life considered the moral issues surrounding vaccines prepared in cell lines descended from aborted fetuses. The Vatican group concluded that it can be both morally permissible and morally responsible for Catholics to use these vaccines.
In general, doctors or parents who resort to the use of these vaccines for their children, in spite of knowing their origin (voluntary abortion), carry out a form of very remote mediate material cooperation, the pontifical academy said.
The duty to avoid passive material cooperation is not obligatory if there is grave inconvenience. Moreover, we find, in such a case, a proportional reason, in order to accept the use of these vaccines in the presence of the danger of favouring the spread of the pathological agent, due to the lack of vaccination of children, it added.
The pontifical academy also noted that Catholics have an obligation to use ethically-sourced vaccines when available, and have an obligation to speak up and request the development of new cell lines that are not derived from aborted fetuses.
The 2008 Congregation for the Doctrine of the Faith document Dignitatis personae strongly criticized aborted fetal tissue research. The CDF said that researchers should refuse the material even when they have no close connection to the actions of those who performed the artificial fertilization or the abortion.
This duty springs from the necessity to remove oneself, within the area of ones own research, from a gravely unjust legal situation and to affirm with clarity the value of human life, the CDF stated.
Regarding common vaccines, such as those for chicken pox and measles, mumps, and rubella (MMR), that may be derived from cell lines of aborted babies, the Vatican has said they could be used by parents for grave reasons such as danger to their childrens health.
Another ethical question at the heart of COVID vaccine production is the speed at which it is taking place.
The hurried development makes it all the more important that bioethicists scrutinize the vaccine, said NCBC president Joseph Meaney in a July 24 statement.
Good bioethicists are nearly always wary when scientific research is rushed forward, and even more so when the potential impact on human beings could be profound, he said.
Brehany echoed that point, telling CNA that a vaccine must be developed and distributed with the informed consent for all recipients about the possible risks, without testing on vulnerable populations especially the poor.
On April 17, leading U.S. bishops wrote Stephen Hahn, commissioner of the Food and Drug Administration (FDA), asking that a COVID vaccine be developed ethically.
It is critically important that Americans have access to a vaccine that is produced ethically: no American should be forced to choose between being vaccinated against this potentially deadly virus and violating his or her conscience, the bishops wrote.
The letter was signed was the chairs of the U.S. Catholic bishops committees on pro-life issues, doctrine, and domestic justice, and subcommittee on health care issues. Leaders of pro-life and bioethics groups, including the National Catholic Bioethics Center, the Catholic Medical Association, and the American College of Pediatricians, also signed the letter.
Brehany said that vaccines derived from cell lines of aborted babies is a very significant bioethical issue that Christians and pro-lifers ought to take seriously.
This is the time to be advocating for alternatives, he said of current COVID vaccine production and ethical sources for vaccines.
Around 30,000 people who are not COVID-positive will be enrolled in the phase 3 testing of the Moderna vaccine. The Food and Drug Administration (FDA) will then review the testing results.
In addition to the Moderna candidate, Trump said that four other vaccine candidates are expected to enter final trials in the coming weeks.
See the original post:
Is the coronavirus vaccine made from fetal cell lines?
- Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platform - FiercePharma - April 19th, 2024
- The Stem Cells Market expected to grow at the value of USD 28.1 Billion by 2030 with a 10.48% CAGR. - WhaTech - April 19th, 2024
- Scientists produce in vitro model of cell differentiation during early facial development - Phys.org - April 19th, 2024
- Somite: AI-Based Stem Cell Therapy Company Closes $5.3 Million In Funding - Pulse 2.0 - April 19th, 2024
- Paralyzed man who can walk again shows potential benefit of stem cell therapy - ABC News - April 5th, 2024
- Stem Cells Market Innovations Investigated by Industry Overview and Global Forecast - WhaTech - April 5th, 2024
- New tool provides researchers with improved understanding of stem cell aging in the brain - University of Wisconsin-Madison - April 1st, 2024
- The PTM profiling of CTCF reveals the regulation of 3D chromatin structure by O-GlcNAcylation - Nature.com - April 1st, 2024
- Signatures of Autofluorescence Used To Study Stem Cells Aging in the Brain - Technology Networks - March 30th, 2024
- Two decades of embryonic stem cells: a historical overview - March 28th, 2024
- Researchers at Phoenix Children's First in the World to Produce Mouse Lungs in Rats - The Malaysian Reserve - March 26th, 2024
- Unlocking the mysteries of early human development through blastoid models - News-Medical.Net - March 24th, 2024
- Unlocking the Secrets of Aging: Researchers Reveal Key to Intestinal Balance - SciTechDaily - March 17th, 2024
- Human stem-cell-based therapy for Parkinson's disease proven safe PET - BioNews - March 13th, 2024
- Exploring the inner workings of stem cells: When location changes the message - Phys.org - March 9th, 2024
- Confronting IVF: Human Embryos Are Persons With a Right to Life - Walter Bradley Center for Natural and Artificial Intelligence - March 7th, 2024
- When Location Changes the Message - UConn Today - University of Connecticut - March 7th, 2024
- Distinct pathways drive anterior hypoblast specification in the implanting human embryo - Nature.com - March 6th, 2024
- In light of the Alabama court ruling, a look at the science of IVF : Short Wave - NPR - March 3rd, 2024
- The weird way Alabamas embryo ruling takes on artificial wombs - MIT Technology Review - February 25th, 2024
- Alabama's biggest hospital to suspend transfer of embryos after court ruling - ABC News - February 24th, 2024
- Stem Cells: FAQs Answered for Patients and Caregivers - Corporate Wellness Magazine - February 22nd, 2024
- Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells - Business Wire - February 22nd, 2024
- Breakthrough Stem Cell Treatments for Stroke Recovery: What You Need to Know - Medical Tourism Magazine - February 20th, 2024
- Global Cell Isolation Market Size To Worth USD 13.4 Billion By 2033 | CAGR of 12.5% - Yahoo Finance - February 20th, 2024
- The Mechanism of Positional Cues in Embryonic Development and Signaling Molecules in Cell Fate - Medriva - February 18th, 2024
- Regeneration of the Retina Using Pluripotent Stem Cells: A Comprehensive Review - Cureus - February 5th, 2024
- CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from ... - Nature.com - January 29th, 2024
- Global Human Embryonic Stem Cell Market Analysis 2024-2034: A Deep Dive into Applications, End-users, and ... - GlobeNewswire - January 26th, 2024
- No, Rep. Steve Scalise Didn't Vote Against Stem Cell Research From Which He Is Now Benefiting - Yahoo News - January 14th, 2024
- Clinical applications of stem cell-derived exosomes | Signal Transduction and Targeted Therapy - Nature.com - January 12th, 2024
- How Stem Cell Embryo Models Won Method of the Year - Technology Networks - January 12th, 2024
- Changing the public perception of human embryology - ESHRE - January 11th, 2024
- How the Human Body Regenerates New Cells Every Year - Laughing Squid - January 4th, 2024
- Lab-grown models of embryos increasingly resemble the real thing | Mint - Mint - January 4th, 2024
- Singapore should ban reproductive applications of synthetic human embryos - BioEdge - January 4th, 2024
- Machine learning-based estimation of spatial gene expression pattern during ESC-derived retinal organoid ... - Nature.com - December 21st, 2023
- The development of embryos may be less shaped by genes than we thought - New Scientist - December 21st, 2023
- Embryonic stem cell - Wikipedia - December 13th, 2023
- Researchers discover a mechanism that controls the identity of stem cells - Phys.org - December 9th, 2023
- 'Fascinating and completely unexpected': Tiny robots fix neurons - FierceBiotech - December 5th, 2023
- Establishment and characterization of matched immortalized human ... - Nature.com - December 5th, 2023
- Proteomic insights into the associations between obesity, lifestyle ... - BMC Medicine - December 5th, 2023
- New therapy can treat rare and hereditary diseases - ScienceNorway - December 5th, 2023
- Scientists Still Can't Be Trusted on Gene Editing - Progressive.org - December 5th, 2023
- Harvard Apparatus Regenerative Technology and Renowned ... - Yahoo Finance - December 5th, 2023
- 4.4 Million Funding Injection Fuels World-Class Bioscience Research Programme - India Education Diary - December 3rd, 2023
- A two-kinesin mechanism controls neurogenesis in the developing ... - Nature.com - December 3rd, 2023
- What happens when nature and cities collide - CNN - December 3rd, 2023
- Pro-Life This Week: December 1, 2023 | ALL - All.org - December 3rd, 2023
- A look at the international race to create human eggs and sperm in ... - NPR - December 1st, 2023
- Synthetic genetic circuits to uncover the OCT4 trajectories of ... - Science - December 1st, 2023
- Why the Novo Nordisk Foundation is betting big on stem cells - pharmaphorum - November 29th, 2023
- Charity Watchlist Helps Donors Ensure Their Year-End Gifts Don't ... - All.org - November 29th, 2023
- A green glowing monkey has been created in China. What were the ... - Genetic Literacy Project - November 29th, 2023
- Fetal Bovine Serum Market to reach USD 1.26 Bn by 2029, emerging at a CAGR of 5.3 percent according to a ne... - WhaTech Technology and Markets News - November 29th, 2023
- Implications of Gene Therapy in Dentistry and Periodontics: A ... - Cureus - November 27th, 2023
- Study shows how to treat hereditary, rare diseases - ETHealthWorld - November 27th, 2023
- Drugs identified that may reverse brain fog caused by COVID-19 - New Atlas - November 27th, 2023
- The genes that made us truly human may also make us ill - BBC.com - November 25th, 2023
- Therapy to treat rare, hereditary diseases: Study - Hindustan Times - November 25th, 2023
- How the growth of a giant single cell is intertwined with daily self-rhythms - Phys.org - November 25th, 2023
- On this day: Mahmoud Abbas becomes leader of Fatah in 2004 - In-Cyprus - November 25th, 2023
- Evaluation of A-ring hydroxymethylene-amino- triterpenoids as ... - Nature.com - November 25th, 2023
- Disruption of the autism gene and chromatin regulator KDM5A alters ... - Science - November 23rd, 2023
- Scientists Created a Monkey With Two Different Sets of DNA - Smithsonian Magazine - November 23rd, 2023
- Genomic tug of war could boost cancer therapy - Science Daily - November 23rd, 2023
- What are stem cells? Throw light on various types of stem cells and ... - Insights IAS - November 23rd, 2023
- The Paul G. Allen Family Foundation awards $10.5 million to new ... - EurekAlert - November 23rd, 2023
- Daily briefing: Why these PhD scientists went into teaching - Nature.com - November 23rd, 2023
- Innovative Therapy Targets Rare, Hereditary Diseases - Mirage News - November 23rd, 2023
- Scientists uncover "genomic tug of war" that influences ... - News-Medical.Net - November 21st, 2023
- DOT1L is a barrier to histone acetylation during reprogramming to ... - Science - November 21st, 2023
- Tumor microenvironment composition & related therapy in HCC | JHC - Dove Medical Press - November 21st, 2023
- T-Therapeutics raises $59M in series A for T-cell receptors - BioWorld Online - November 19th, 2023
- A $3bn bet on finding the fountain of youth | Mint - Mint - November 19th, 2023
- A better way to study Parkinson's disease in the lab could lead to ... - EurekAlert - November 17th, 2023
- Global Stem Cell Therapy Market to Reach USD 928.6 Million by ... - GlobeNewswire - November 17th, 2023
- MKL/SRF and Bcl6 mutual transcriptional repression safeguards the ... - Science - November 17th, 2023
- METTL1-Related Genes and Immune Characteristics in SLE | JIR - Dove Medical Press - November 17th, 2023
Recent Comments